MEDINDIA
English
हिन्दी
Español
français
中文
Covishield, India's first coronavirus vaccine will roll out in the coming weeks, said Adar Poonawalla, CEO, Serum Institute of India (SII).
COVID-19 Vaccine to be Free in India
Union Health Minister Harsh Vardhan said that the vaccine will be free across the country. India has recorded the second highest numbers of corona infections after the United States.
Union Health Minister Harsh Vardhan said that the vaccine will be free across the country. India has recorded the second highest numbers of corona infections after the United States.
TOP INSIGHT
Covishield, India's first coronavirus vaccine will roll out in the coming weeks.
"Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks", he said in a tweet.
"Thank you Hon. Sri@narendramodiJi, Hon. Sri@drharshvardhanJi @MoHFW_INDIA @ICMRDELHI @DBTIndia #DCGI_India @UniofOxford @AstraZeneca @gavi @GaviSeth @gatesfoundation and @BillGates for your support", he added.
COVID-19 Vaccines Demonstrate Its Safe Efficacy
COVID-19 vaccines produced by Pfizer-BioNTech and Moderna, have demonstrated safety even in patients with severe allergies to foods, oral drugs, latex, or venom.
COVID-19 vaccines produced by Pfizer-BioNTech and Moderna, have demonstrated safety even in patients with severe allergies to foods, oral drugs, latex, or venom.
Oxford COVID-19 Vaccine: Here's What You Need To Know
Serum Institute of India (SII) has a stockpile 40-50 million doses of its COVID-19 vaccine and India is likely to receive majority of these 50 million doses.
Serum Institute of India (SII) has a stockpile 40-50 million doses of its COVID-19 vaccine and India is likely to receive majority of these 50 million doses.
First Self-developed COVID-19 Vaccine
China announced that it had granted conditional marketing authorization for the first COVID-19 vaccine. The inactivated vaccine is developed by the Beijing Biological Products Institute.
China announced that it had granted conditional marketing authorization for the first COVID-19 vaccine. The inactivated vaccine is developed by the Beijing Biological Products Institute.
Email
